海南海药
(000566)
| 流通市值：88.84亿 | | | 总市值：98.86亿 |
| 流通股本：11.66亿 | | | 总股本：12.97亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 639,683,832.92 | 450,274,958.78 | 206,597,801.19 | 990,701,458.53 |
| 营业收入 | 639,683,832.92 | 450,274,958.78 | 206,597,801.19 | 990,701,458.53 |
| 二、营业总成本 | 926,345,895.47 | 632,766,596.94 | 293,042,321.24 | 1,398,076,695.25 |
| 营业成本 | 475,305,790.5 | 322,850,103.04 | 144,675,146.73 | 641,692,184.13 |
| 税金及附加 | 15,121,455.89 | 10,874,909.5 | 4,502,094.88 | 19,233,165.83 |
| 销售费用 | 113,371,830.98 | 85,922,946.64 | 42,027,272.68 | 274,387,197.78 |
| 管理费用 | 170,125,032.47 | 110,802,084.31 | 50,622,411.04 | 228,414,014.42 |
| 研发费用 | 27,335,705.41 | 21,518,579.22 | 14,505,089.72 | 58,621,438.42 |
| 财务费用 | 125,086,080.22 | 80,797,974.23 | 36,710,306.19 | 175,728,694.67 |
| 其中:利息费用 | 125,342,244.07 | 81,707,214.08 | 37,205,194.45 | 176,506,755.8 |
| 其中:利息收入 | 1,006,298.75 | 1,305,979.94 | 774,902.38 | 717,119.06 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 167,575.24 | 721,897.39 | 132,689.45 | -357,385,227.15 |
| 加:投资收益 | 6,038,962.2 | -1,207,563.84 | 6,234,747.89 | -68,356,604.55 |
| 资产处置收益 | -63,995.28 | 3,256,591.08 | -68,010.91 | 944,867.89 |
| 资产减值损失(新) | -206,323.33 | -206,323.33 | 90,281.56 | -361,749,130.19 |
| 信用减值损失(新) | 1,380,394.64 | -6,109,709.85 | -2,630,290.72 | -386,844,025.77 |
| 其他收益 | 21,188,544.39 | 18,040,449.83 | 6,114,690.92 | 30,816,706.34 |
| 四、营业利润 | -258,156,904.69 | -167,996,296.88 | -76,570,411.86 | -1,549,948,650.15 |
| 加:营业外收入 | 298,810.09 | 269,446.84 | 11,991.83 | 816,403.1 |
| 减:营业外支出 | 1,130,864.32 | 814,292.11 | 264,030.14 | 12,031,660.79 |
| 五、利润总额 | -258,988,958.92 | -168,541,142.15 | -76,822,450.17 | -1,561,163,907.84 |
| 减:所得税费用 | 3,656,564.9 | 3,480,399.08 | -537,532.49 | 34,036,741.57 |
| 六、净利润 | -262,645,523.82 | -172,021,541.23 | -76,284,917.68 | -1,595,200,649.41 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -262,645,523.82 | -172,021,541.23 | -76,284,917.68 | -1,595,200,649.41 |
| 终止经营净利润 | - | - | - | 0 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -242,307,257.15 | -158,307,106.28 | -68,365,454.56 | -1,525,200,923.81 |
| 少数股东损益 | -20,338,266.67 | -13,714,434.95 | -7,919,463.12 | -69,999,725.6 |
| 扣除非经常损益后的净利润 | -272,391,155.14 | -180,590,505.99 | -79,028,738.03 | -1,194,655,379.91 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.19 | -0.12 | -0.05 | -1.18 |
| (二)稀释每股收益 | -0.19 | -0.12 | -0.05 | -1.18 |
| 八、其他综合收益 | -520,704.64 | -604,695.64 | -142,350.18 | -3,699,459.01 |
| 归属于母公司股东的其他综合收益 | -520,704.64 | -604,695.64 | -142,350.18 | -1,737,909.01 |
| 九、综合收益总额 | -263,166,228.46 | -172,626,236.87 | -76,427,267.86 | -1,598,900,108.42 |
| 归属于母公司股东的综合收益总额 | -242,827,961.79 | -158,911,801.92 | -68,507,804.74 | -1,526,938,832.82 |
| 归属于少数股东的综合收益总额 | -20,338,266.67 | -13,714,434.95 | -7,919,463.12 | -71,961,275.6 |
| 公告日期 | 2025-10-30 | 2025-08-27 | 2025-04-30 | 2025-04-12 |
| 审计意见(境内) | | | | 标准无保留意见 |